Medical Drone Startup to Begin Covid Vaccine Delivery in April
(Bloomberg) -- Zipline Inc., a drone delivery service that specializes in medical supplies, announced Thursday that it plans to begin transporting COVID-19 vaccines in April. The South San Francisco-based startup said in a release that it is partnering with “a leading manufacturer of COVID-19 vaccines” in all of the markets where its drones currently operate. Zipline has been delivering medicine and supplies to rural clinics in Rwanda and Ghana since 2016 and, last year, began delivering personal protective equipment to hospitals and clinics in North Carolina. It plans to add operations in Nigeria later this year.
Zipline declined to specify its vaccine partner but said it has built a system that can deliver ultra-low temperature medical supplies, including “all leading COVID-19 vaccines.” The vaccine developed by Pfizer Inc and BioNTech SE must be stored in extreme cold at temperatures of negative 70 degrees Celsius, requiring special freezers. Zipline plans to add these ultra cold refrigerators at all of its distribution centers.
Pfizer, responding to an earlier request for comment about whether it is working with Zipline, on Thursday said in a statement, “Pfizer supports Zipline's efforts to expand access to vaccines and medicines to those in hard to reach geographies.”
Vaccine distribution sites without ultra-low refrigeration have limited options: They can forego Pfizer's vaccine entirely opting for the Moderna Inc. alternative and hoping for additional vaccines from Johnson & Johnson and others to gain FDA approval; keep Pfizer's vaccine vials on dry ice for up to 30 days; or keep them in standard refrigerators for up to five days. Zipline can help bypass the need for freezers — and prevent vaccines from spoiling — by repeatedly supplying a small numbers of doses on demand. A clinic in its network, the company says, will be able to request a few dozen doses of a COVID-19 vaccine and receive them at an ultra low temperature in less than an hour.
Zipline's fixed-wing, battery-powered drones navigate by GPS. They drop payloads of a few pounds each by parachute and can fly up to 100 miles round trip. A single distribution site can operate dozens of drones and supply an area of up to 8,000 square miles. The company says its drones have flown more than 4 million miles and made nearly 400,000 deliveries in the last five years.
“Any innovative option for delivering vaccines to rural communities is a great idea,” said Alan Morgan, chief executive officer at the National Rural Health Association. When Pfizer began rolling out its vaccine in December, Morgan feared that communities outside the reach of the ultra-cold supply chain would be left behind. So far, he says, that has not been the case, as rural clinics have been able to get deliveries packed in dry ice and get injections into arms quickly. “But once we start moving this into the general population,” he says, “getting to these small and remote towns is going to be an issue.”
Zipline CEO Keller Rinaudo said the company wants to help rural areas that have been hard hit by the coronavirus. “Where you live shouldn't determine whether or not you get a COVID-19 vaccine,” he said in the release. “We can help health systems bypass infrastructure and supply chain challenges through instant delivery.”
©2021 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.